A team of researchers has uncovered how cancer evades the immune system and spreads throughout the body and is investigating ways to disable this potentially harmful trait.
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
Options for treatment are limited when cancer spreads to the brain. The majority of medications made to fight metastases either cannot penetrate the blood-brain barrier or are ineffective against brain metastases.
The University of Cincinnati's researchers have created a similar strategy for treating cancer, connecting cancer cells to potent radiation therapy with bacteria acting as the adaptor.
CAR T-cell treatments, which are specifically designed to target cancer cells, has heralded a new era in the treatment of human cancers, particularly hematologic malignancies. But all too frequently, they exhibit a disconcerting characteristic derived from the immune system's own cells: a sh
Isolated from other cells in a laboratory dish, tumour cells won't reveal their actual nature. Rice University researchers created an improved tumour model that houses osteosarcoma cells alongside immune cells known as macrophages inside a three-dimensional framework designed to simulate bon
A team of scientists led by Dr Kei-ichi TAKATA from the Institute for Basic Science's Center for Genomic Integrity (CGI) discovered a new type of DNA repair mechanism that cancer cells use to recover from next-generation cancer radiation therapy.
A cell's ability to multiply and divide is necessary for life, resulting in the evolution of complex creatures from a single cell. It also allows worn-out cells to be replaced by a small number of "stem" cells, which subsequently multiply and specialise. Yet, in cancer, cell growth is no lon
Gurgaon (Haryana) [India], March 14 (ANI/BusinessWire India): Art of Healing Cancer, a leading cancer care provider in India, is pleased to share information on the role of liquid biopsy in the management of cancer. This technique is revolutionising cancer care by providing a non-invasive an
A research team from the University of Copenhagen has been successful in stopping invasive growth in a skin cancer model by utilising synthetic human skin.
A new weapon in the arsenal of cancer cells' treatment resistance, according to a study conducted by the Garvan Institute of Medical Research, is the ability for them to respond randomly to chemotherapy.